Skip header and navigation

25 records – page 1 of 2.

Date Research Question / Title Unique ID Research Team
June 7, 2022 What is the efficacy of a 4th booster dose for COVID-19? EOC220304v002 RR EOC
June 6, 2022 What is known about hybrid immunity to COVID-19? INF220501 RR Infectious Disease
May 27, 2022 What is the evidence on timing and outcomes of elective surgery after a COVID infection? EOC220504 RR EOC
May 24, 2022 When should post-COVID infected patients receive booster shots? EOC220503 RR EOC
May 10, 2022 Is there an optimal interval between the administration of COVID-19 early intervention therapeutic products and COVID-19 vaccination? EOC220501 RR EOC
May 2022 Motivational Interviewing for Vaccine Hesitancy - Situation, Background, Assessment, Recommendation (SBAR) EOC220301 SBAR EOC
March 10, 2022 What is the safety/efficacy of the Novavax COVID-19 vaccine? EOC220302 RR EOC
February 10, 2022 What are the latest health policy definitions of being fully vaccinated? EOC220101 RR EOC
February 4, 2022 Is there evidence that children under 18 should receive the booster to increase their immunity? EOC220102 RR EOC
February 4, 2022 What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines? EOC220103 RR EOC
December 26, 2021 How effective are COVID-19 vaccines? [Evergreen] INF031801v019 RR Infectious Disease
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR EOC
August 24, 2021 What are other jurisdictions offering for incentive-based COVID-19 vaccine campaigns? EOC210501v2 RR EOC
August 17, 2021 What are the causes of vaccine hesitancy? What programs/approaches have been successful in reducing vaccine hesitancy? EOC012201v3 RR EOC
June 21, 2021 What are the ethical/legal aspects of vaccine requirements? EOC210503 RR EOC
June 10, 2021 What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view? EOC210502 RR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
March 30, 2021 What are the effects of the new COVID variants on transmission and school reopenings in pediatric populations? PH030801 RR Public Health
March 29, 2021 What impact does COVID-19 vaccination have on visitation policies and transmission rates in LTC? LTC012501 RR Long Term Care
March 18, 2021 What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? EOC031001 RR EOC

25 records – page 1 of 2.